Cannabix Technologies and Omega Laboratories have developed a breath-based drug testing panel that detects recent use of multiple drug classes, modeled after the federally mandated DOT urine drug test panel. This new breath test can identify amphetamines, cocaine, marijuana, opiates, and PCP within minutes to hours after use, offering a more immediate and relevant detection window compared to traditional urine or hair tests. The test uses mass spectrometry for high accuracy and is designed for safety-sensitive environments such as workplaces, courts, and law enforcement. This advancement aims to improve decision-making by focusing on recent drug use rather than historical use, with the breath test currently available to clients and expected to complement existing drug testing methods.
Mama's Creations reported a strong quarter with revenue up 55% and EBITDA up 70%, driven by solid organic growth and successful integration of Crown. The company holds $138.6 million in cash, positioning it well for a significant acquisition to help ...
The 10-year U.S. Treasury yield faces a critical test at 4.8%, with a sustained rise above this level potentially causing significant problems across various asset classes. Rising fiscal deficits, heavy government debt issuance, and strong corporate ...
Bitcoin's recent price rebound near $82,000 saw a surge in leveraged trading on Binance, with open interest briefly surpassing $10 billion. However, this leverage has since cooled, reducing liquidation risks and potentially stabilizing the rally. Min...
Jupiter (JUP) surged 18.86% to $0.2670, leading crypto market gains due to growing interest in its blockchain solutions focused on data privacy and security. Other notable gainers included Zcash, Bittensor, NEAR Protocol, and Polkadot, while Pons and...
Conagra is rated a Buy due to low investor expectations, conservative management guidance, and clear turnaround catalysts. Near-term margin pressures are expected to be offset by pricing actions, productivity improvements, and reinvestments in brands...
